AN4005
Phase 1- Indications
- Advanced malignancies
Company intelligence / Profile preview
Xiamen Biotime Biotechnology
Xiamen, Fujian, Chinaxiamenbiotime.com ↗
- Ownership
- Public · BTX
- Employees
- ~95
- Development stage
- Phase 1
01
Overview
Xiamen Biotime Biotechnology develops and commercializes a wide portfolio of point-of-care testing devices and reagents covering major health areas such as cardiology/hormones/cancer/diabetes/infectious diseases. The company holds over fifty patents with more than sixty NMPA registrations and thirty-five CE certifications. It has recently expanded into innovative drug development through licensing agreements with biopharma partners like Adlai Nortye—these include early-stage oncology assets targeting PD-L1/TNFR2 now in Phase I trials or earlier stages. The company maintains strong R&D collaborations with academic institutions to drive innovation in rapid diagnostics technology.
- Therapeutic areas
- OncologyEndocrinologyImmunologyCardiovascularNephrologyInfectious Diseases
- Modalities
- DeviceDiagnostic reagentImmunoassayRapid test kitSmall moleculeMonoclonal antibody
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Adlai NortyeSanford-Burnham Medical Research InstituteXiamen UniversityThird Institute of Oceanography
04
Financials
- Market cap
- $1B
- Enterprise value
- $1B
Beyond the preview
Go deeper on Xiamen Biotime Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xiamen Biotime Biotechnology.